ATE223045T1 - Inhibierung der amulin-freisetzung - Google Patents

Inhibierung der amulin-freisetzung

Info

Publication number: ATE223045T1
Authority: AT; Austria
Prior art keywords: compound; sstr; release; ligand; amylin
Prior art date: 1995-05-12

Application number

AT96914208T

Other languages

English (en)

Inventor

Simon Jon Dunmore

Michelle Davenport

Michael Anthony Cawthorne

Original Assignee

Univ Buckingham

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-12

Filing date

1996-05-11

Publication date

2002-09-15

1996-05-11 Application filed by Univ Buckingham filed Critical Univ Buckingham

2002-09-15 Application granted granted Critical

2002-09-15 Publication of ATE223045T1 publication Critical patent/ATE223045T1/de

Links

230000005764 inhibitory process Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 7
102000036770 Islet Amyloid Polypeptide Human genes 0.000 abstract 5
108010041872 Islet Amyloid Polypeptide Proteins 0.000 abstract 5
239000003446 ligand Substances 0.000 abstract 4
238000000034 method Methods 0.000 abstract 3
102000005157 Somatostatin Human genes 0.000 abstract 1
108010056088 Somatostatin Proteins 0.000 abstract 1
230000035877 hyperamylinemia Effects 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 abstract 1
229960000553 somatostatin Drugs 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/655—Somatostatins
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Hematology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Organic Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Zoology (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Steroid Compounds (AREA)
Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
Medicines Containing Plant Substances (AREA)

AT96914208T 1995-05-12 1996-05-11 Inhibierung der amulin-freisetzung ATE223045T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/440,061 US5763200A (en)	1995-05-12	1995-05-12	Inhibition of amylin release
PCT/EP1996/002064 WO1996035950A1 (en)	1995-05-12	1996-05-11	Inhibition of amylin release

Publications (1)

Publication Number	Publication Date
ATE223045T1 true ATE223045T1 (de)	2002-09-15

Family

ID=23747259

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96914208T ATE223045T1 (de)	1995-05-12	1996-05-11	Inhibierung der amulin-freisetzung

Country Status (13)

Country	Link
US (3)	US5763200A (de)
EP (1)	EP0829011B1 (de)
JP (1)	JPH11505611A (de)
AT (1)	ATE223045T1 (de)
AU (1)	AU694360B2 (de)
CA (1)	CA2220106A1 (de)
DE (1)	DE69623280T2 (de)
DK (1)	DK0829011T3 (de)
ES (1)	ES2180769T3 (de)
MX (1)	MX9708740A (de)
NZ (1)	NZ308105A (de)
PT (1)	PT829011E (de)
WO (1)	WO1996035950A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU8019798A (en) *	1997-05-13	1998-12-08	Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)	Method and compositions for treating hyperlipidemia and other conditions
PT980253E (pt) *	1997-05-13	2004-08-31	Conseils De Rec Appl Scient S	Somatostatina e agonistas de somatostatina para tratar a insensibilidade a insulina e a sindrome x
PT981363E (pt) *	1997-05-13	2003-12-31	Conseils De Rec Appl Scient S	Somatostatina e agonistas da somatostatina para reduzir o peso corporal
US6004928A (en) *	1997-05-13	1999-12-21	Biomeasure, Incorporated	Method of treating hyperlipidemia
WO1999012572A1 (en) *	1997-09-10	1999-03-18	University Of Florida	Compounds and method for the prevention and treatment of diabetic retinopathy
CA2325169A1 (en)	1999-12-03	2001-06-03	Ndsu Research Foundation	Somatostatins and method
EP1369698A1 (de) *	2002-06-07	2003-12-10	Bayer Ag	Diagnostik- und Therapie- Verfahren von mit Somatostatin Rezeptor 5 (SSTR5) verbundenen Krankheiten
DK1675625T3 (da) *	2003-09-17	2013-05-13	Univ Texas	Mekanisme-baseret målrettet pancreatisk beta-celle-afbildning
JP4365743B2 (ja) *	2004-07-27	2009-11-18	富士通マイクロエレクトロニクス株式会社	撮像装置
EP3746459A1 (de)	2018-02-02	2020-12-09	Univerza V Ljubljani	Affinitätsliganden für antikörper-fc-region

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5260275A (en) *	1990-08-14	1993-11-09	Amylin Pharmaceuticals, Inc.	Hypoglycemics
US5234906A (en) *	1991-01-10	1993-08-10	Amylin Pharmaceuticals, Inc.	Hyperglycemic compositions
US5436155A (en) *	1991-12-31	1995-07-25	Arch Development Corporation	Isolated DNA encoding a somatostatin receptor

1995
- 1995-05-12 US US08/440,061 patent/US5763200A/en not_active Expired - Fee Related
1996
- 1996-05-11 DK DK96914208T patent/DK0829011T3/da active
- 1996-05-11 JP JP8533796A patent/JPH11505611A/ja active Pending
- 1996-05-11 AT AT96914208T patent/ATE223045T1/de not_active IP Right Cessation
- 1996-05-11 EP EP96914208A patent/EP0829011B1/de not_active Expired - Lifetime
- 1996-05-11 DE DE69623280T patent/DE69623280T2/de not_active Expired - Fee Related
- 1996-05-11 AU AU57645/96A patent/AU694360B2/en not_active Ceased
- 1996-05-11 PT PT96914208T patent/PT829011E/pt unknown
- 1996-05-11 NZ NZ308105A patent/NZ308105A/en unknown
- 1996-05-11 MX MX9708740A patent/MX9708740A/es unknown
- 1996-05-11 ES ES96914208T patent/ES2180769T3/es not_active Expired - Lifetime
- 1996-05-11 WO PCT/EP1996/002064 patent/WO1996035950A1/en not_active Ceased
- 1996-05-11 CA CA002220106A patent/CA2220106A1/en not_active Abandoned
1997
- 1997-10-31 US US08/961,968 patent/US6774109B2/en not_active Expired - Fee Related
2004
- 2004-01-08 US US10/753,717 patent/US20040146951A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU5764596A (en)	1996-11-29
CA2220106A1 (en)	1996-11-14
JPH11505611A (ja)	1999-05-21
DE69623280T2 (de)	2003-05-22
US5763200A (en)	1998-06-09
US6774109B2 (en)	2004-08-10
ES2180769T3 (es)	2003-02-16
DE69623280D1 (de)	2002-10-02
EP0829011A1 (de)	1998-03-18
US20010006790A1 (en)	2001-07-05
NZ308105A (en)	1999-04-29
AU694360B2 (en)	1998-07-16
DK0829011T3 (da)	2002-10-28
WO1996035950A1 (en)	1996-11-14
EP0829011B1 (de)	2002-08-28
MX9708740A (es)	1997-12-31
PT829011E (pt)	2003-01-31
US20040146951A1 (en)	2004-07-29

Legal Events

Date	Code	Title	Description
2002-12-15	UEP	Publication of translation of european patent specification
2004-08-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
CA2167048A1 (en)	1995-01-26	Identification of ligands by selective amplification of cells transfected with receptors
NO970891L (no)	1997-02-27	Aerogelholdige komposittmaterialer, fremgangsmåte for fremstilling av disse samt deres anvendelse
DE69901714D1 (de)	2002-07-11	Elektrochemischer affinitätsassay
ATE223045T1 (de)	2002-09-15	Inhibierung der amulin-freisetzung
EP0803577A3 (de)	1998-12-02	Verfahren zur Detektion und/oder Bestimmung von ATP aus Mikroorganismcellen in einer Probe
DE69735127D1 (de)	2006-04-06	Enzymsensor
AU6383396A (en)	1996-12-30	Beta-secretase, antibodies to beta-secretase, and assays for detecting beta-secretase inhibition
KR900700591A (ko)	1990-08-16	세포 혼합물로부터 특정 세포를 분리하는 다단계 친화방법
WO2000005265A3 (en)	2000-04-27	Anti-crr2 antibodies and methods of use therefor
DE3775224D1 (de)	1992-01-30	Protonenleitergassensor und verfahren zum gasnachweis unter benutzung desselben.
EP0734264A4 (de)	1999-04-21	Verbindungen die spezifisch an kolorektale krebszellen binden und verfahren fuerihre herstellung
TR200101834T2 (tr)	2001-12-21	Yeni tiroid reseptör ligandları ve yöntem II
TR199802572T2 (xx)	1999-03-22	V�cut a��rl��n� ayarlamada elveri�li bile�ikleri tesbit i�in tarama y�ntemleri.
EP0496832A4 (en)	1993-02-17	Inhibition of padgem-mediated cell binding
EP0199801A4 (de)	1988-12-15	Ergänzungstestverfahren von proteine bindenden enzymen.
ES2057571T3 (es)	1994-10-16	Receptor de pdgf-alfa.
ES2148967T3 (es)	2000-10-16	Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia.
EP0188068A3 (en)	1986-10-01	Method for purifying reaction solution obtained by using microbial cell, immobilized microbial cell, or immobilized enzyme
WO2001007088A3 (en)	2001-11-15	Methods for treating therapy-resistant tumors
CA2225210A1 (en)	1997-01-09	Receptor:release ligand (reland) complexes and assays and kits based thereon
WO2003019136A3 (en)	2003-11-20	Methods for inhibiting angiogenesis
WO2000000599A3 (en)	2000-03-23	Composition for the induction of apoptosis in target cells
GB2342652A (en)	2000-04-19	Polypeptides comprising a coiled-coil and an addition
WO2001048466A3 (de)	2002-02-21	Sensorelement eines gassensors zur bestimmung von gaskomponenten
WO2000077241A3 (en)	2001-03-22	Heparanase assay